19 May 2013
Keywords: isis, gets, 2m, b-ms, selects, first, pcsk9
Article | 14 April 2008
US drug major Bristol-Myers Squibb has selected a compound from its collaboration with Isis Pharmaceuticals, triggering a $2.0-million
milestone payment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 April 2008
7 April 2008
17 May 2013
© 2013 thepharmaletter.com